Lancet Series Article Calls for Changes to Approach to Fighting HIV-Associated TB
May 28, 2010
"The advent of ART [antiretroviral therapy] has been the most important event in tuberculosis control since the epidemic of HIV-associated tuberculosis began. However, the full potential of ART, in combination with HIV testing, tuberculosis screening, infection control, and isoniazid and co-trimoxazole preventive therapy, has yet to be realized," write the authors of a Lancet Series article that focuses on the situation in sub-Saharan Africa, "the epicenter of the HIV-associated tuberculosis epidemic." The piece features a "review of the interim international policy guidelines for collaborative tuberculosis and HIV activities," and an analysis of the logistics of delivery of HIV/AIDS treatment and TB prevention, among other things. The authors also make recommendations for the scaling up of HIV-TB prevention, testing and treatment (Harries et al., 5/29).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)